OTC · MYCOF
Noveris Health Sciences Inc.
$0.73$0.00 (0.0%)
Noveris Health Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.22% below the high.
Loading market information…
OTC · CHOOF · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Choom Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Choom Holdings Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Choom Holdings Inc., along with its various divisions, specializes in the retail sector of the cannabis industry. The company offers a diverse selection of cannabis products in addition to an extensive array of accessories designed for consumption. These supplementary items include essentials like rolling papers, holders, and various smoking apparatus such as pipes, water pipes, and bongs, as well as modern devices like vaporizers. By June 30, 2021, Choom had established and was operating 17 retail outlets across Canada. Founded in 2006, the Vancouver, Canada-based company rebranded as Choom Holdings Inc. in November 2017, having previously operated under the name Standard Graphite Corporation.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:57 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.73$0.00 (0.0%)
Noveris Health Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.22% below the high.
$0.08$0.00 (0.0%)
Global Pharmatech, Inc.’s quoted price sits in the upper half of its reported 52-week range, 24.44% below the high.
$1.51$0.00 (0.0%)
Raphael Pharmaceutical Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
CA$0.07-CA$0.00 (0.0%)
MediPharm Labs Corp.’s quoted price sits in the lower half of its reported 52-week range, 35.0% below the high.
CA$0.11+CA$0.01 (+5.0%)
Avicanna Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.13% below the high.
$0.00-$0.00 (-9.38%)
Institute of Biomedical Research Corp.’s quoted price sits in the lower half of its reported 52-week range, 91.27% below the high.
$0.00$0.00 (0.0%)
Molecule Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.01$0.00 (0.0%)
Many Bright Ideas Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.0% below the high.
